HHS NIH SBIR Phase II

Venture Capital

Part of HHS

US federal non-dilutive grant program funding small business R&D commercialization in health, biotech, and life sciences.

Seed
Early Stage
Biotech
Digital Health
Healthcare
Life Sciences
Medical Devices
Headquarters
Bethesda, United States
Founded
1982
Total Investments
5
Last Investment
Jan 2025
Geographic Focus
United States

Investment Thesis

Non-dilutive federal grants to continue Phase I R&D efforts, advancing health and biotech innovations from bench to bedside toward commercialization.

HHS NIH SBIR Phase II is a Venture Capital firm based in Bethesda, United States. It has made 5 investments in Biotech and Digital Health.

Investment History

Sign up to view investment history

Create a free account to see deal history, investment amounts, and round details.

Create Free Account